Onder, S. Et Al. 2017. Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis. BREAST JOURNAL , vol.23, no.6 , 638-646.

Onder, S., Fayda, M., Karanlik, H., Bayram, A., Sen, F., Cabioglu, N., ... Tuzlali, S.(2017). Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis. BREAST JOURNAL , vol.23, no.6, 638-646.

Onder, Semen Et Al. "Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis," BREAST JOURNAL , vol.23, no.6, 638-646, 2017

Onder, Semen Et Al. "Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis." BREAST JOURNAL , vol.23, no.6, pp.638-646, 2017

Onder, S. Et Al. (2017) . "Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis." BREAST JOURNAL , vol.23, no.6, pp.638-646.

@article{article, author={Semen ÖNDER Et Al. }, title={Loss of ARID1A expression is associated with poor prognosis in invasive micropapillary carcinomas of the breast: A clinicopathologic and immunohistochemical study with long-term survival analysis}, journal={BREAST JOURNAL}, year=2017, pages={638-646} }